3PBIOVIAN Contributes to Advancing Personalized Cancer Immunotherapies Through the PITÁGORAS ProjectAugust 6, 2026Read more >
3PBIOVIAN reinforces its commitment to continuous learning through UPNA micro-credentialsMay 28, 2026Read more >